CIM
HALO icon

Chiron Investment Management’s Halozyme HALO Stock Holding History

Chiron Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,502
Closed -$1.35M – 103
2024
Q3 		$1.35M Buy
23,502
+4,491
+24% +$257K 0.47% 47
2024
Q2 		$995K Buy
+19,011
New +$834K 0.39% 37
2023
Q2 		– Sell
-25,386
Closed -$969K – 152
2023
Q1 		$969K Buy
+25,386
New +$1.19M 0.17% 62

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chiron Investment Management's HALO Position: Q4 2024 in Review

Chiron Investment Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 23,502 shares — an estimated $1.35M sold.

Chiron Investment Management first reported a position in HALO in Q1 2023 and held it in 3 quarters. The position peaked at $1.35M in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Chiron Investment Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Chiron Investment Management sold 23,502 Halozyme shares in Q4 2024, an estimated $1.35M.
  • Chiron Investment Management first reported a position in Halozyme in Q1 2023 and held it in 3 quarters.
  • Chiron Investment Management's Halozyme position peaked at $1.35M in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Chiron Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.